Showing papers by "Katarzyna Wac published in 2017"
27 Oct 2017
TL;DR: It is suggested that emotion recognition accuracy varies as a function of the modality, and a higher degree of anthropomorphism does not necessarily lead to a higher level of recognition accuracy.
Abstract: Socially assistive agents, be it virtual avatars or robots, need to engage in social interactions with humans and express their internal emotional states, goals, and desires. In this work, we conducted a comparative study to investigate how humans perceive emotional cues expressed by humanoid robots through five communication modalities (face, head, body, voice, locomotion) and examined whether the degree of a robot's human-like embodiment affects this perception. In an online survey, we asked people to identify emotions communicated by Pepper - a highly human-like robot and Hobbit - a robot with abstract humanlike features. A qualitative and quantitative data analysis confirmed the expressive power of the face, but also demonstrated that body expressions or even simple head and locomotion movements could convey emotional information. These findings suggest that emotion recognition accuracy varies as a function of the modality, and a higher degree of anthropomorphism does not necessarily lead to a higher level of recognition accuracy. Our results further the understanding of how people respond to single communication modalities and have implications for designing recognizable multimodal expressions for robots.
30 citations
TL;DR: Report here is a summary of the proceedings of the second session, which reviewed the determinants of GH therapy response, factors affecting GH therapy adherence and the development of innovative technologies to improve GH treatment in children.
Abstract: Poor adherence with growth hormone (GH) therapy has been associated with worse clinical outcomes, which in children relates specifically to their linear growth and loss of quality of life. The "360° GH in Europe" meeting, held in Lisbon, Portugal, in June 2016 and funded by Merck KGaA (Germany), examined many aspects of GH diseases. The three sessions, entitled "Short Stature Diagnosis and Referral," "Optimizing Patient Management," and "Managing Transition," each benefited from three guest speaker presentations, followed by an open discussion and are reported as a manuscript, authored by the speakers. Reported here is a summary of the proceedings of the second session, which reviewed the determinants of GH therapy response, factors affecting GH therapy adherence and the development of innovative technologies to improve GH treatment in children. Response to GH therapy varies widely, particularly in regard to the underlying diagnosis, although there is little consensus on the definition of a poor response. If the growth response is seen to be less than expected, the possible reasons should be discussed with patients and their parents, including compliance with the therapy regimen. Understanding and addressing the multiple factors that influence adherence, in order to optimize GH therapy, requires a multi-disciplinary approach. Because therapy continues over many years, various healthcare professionals will be involved at different periods of the patient's journey. The role of the injection device for GH therapy, frequent monitoring of response, and patient support are all important for maintaining adherence. New injection devices are incorporating electronic technologies for automated monitoring and recording of clinically relevant information on injections. Study results are indicating that such devices can at least maintain GH adherence; however, acceptance of novel devices needs to be assessed and there remains an on-going need for innovations.
25 citations
TL;DR: Beyond wearables that capture and transmit their vitals, QoL technologies present a variety of opportunities for extending the human health, not just how long the authors live, but how well they are.
Abstract: As we embrace digital health technology applications, computing power is increasingly exploited for its capacity to improve our quality of life (QoL). Beyond wearables that capture and transmit our vitals, QoL technologies present a variety of opportunities for extending the human health spana#x2014;not just how long we live, but how well we are.